Filtered By:
Condition: Migraine
Vaccination: Vaccines

This page shows you your search results in order of date. This is page number 20.

Order by Relevance | Date

Total 872 results found since Jan 2013.

Self-reported adverse events within the seven days following the Spikevax ® (Moderna) vaccination
CONCLUSIONS: Our results are consistent with previous studies, identifying women, people aged 18-55 years and those with previous COVID- 19 infection as those who experienced the greatest reactogenicity to the vaccine. A relationship was also found between reactogenicity and suffering from a chronic disease other than hypertension.PMID:36183231
Source: Farmacia Hospitalaria - October 2, 2022 Category: Drugs & Pharmacology Authors: Dulce Guerra-Est évez Cristina Palomo-Palomo Alberto Parrado-Gonz ález Julia Estaire-Guti érrez Miguel Reyes-Malia M Mercedes Romero-Alonso Source Type: research

Changes in Behavior After Vaccination and Opinions Toward Mask Wearing: Thoracic Oncology Patient-Reported Experiences During the COVID-19 Pandemic
CONCLUSIONS: Acceptance of the COVID-19 vaccination among thoracic oncology patients in Germany was high. Overall, patients with thoracic malignancies tolerated the COVID-19 vaccination well. Rate of adverse reaction was not higher compared with the general population. After the vaccination, patients increased social contacts and usage of public transport. These changes suggest positive psychological effects on quality of life. While reducing social distancing can increase the risk of infection, our results indicate that an extension of mask mandates after the pandemic would likely be accepted by a majority of thoracic onc...
Source: Clinical Lung Cancer - September 30, 2022 Category: Cancer & Oncology Authors: Toki Bolt Amanda Tufman Laura Sellmer Kathrin Kahnert Pontus Mertsch Julia Kov ács Diego Kauffmann-Guerrero Dieter Munker Farkhad Manapov Christian Schneider Juergen Behr Julia Walter Source Type: research

Fatal intracerebral haemorrhage associated with thrombosis with thrombocytopenia syndrome after ChAdOx1-S vaccine
CONCLUSIONS: TTS is a rare adverse effect of ChAdOx1-S vaccine, defined by the presence of thrombosis in uncommon locations. In our case we report an spontaneous intracerebral haemorrhage probable due to the thrombocytopenia related to probable TTS. It represents a rare clinical presentation of TTS.PMID:36169326 | DOI:10.33588/rn.7507.2021323
Source: Revista de Neurologia - September 28, 2022 Category: Neurology Authors: A G ómez-Roldós M Gonz ález-Sánchez M Vales-Montero P V ázquez-Alen Y Fern ández-Bullido A M Iglesias-Mohedano F D íaz-Otero A Garc ía-Pastor A Gil-N úñez Source Type: research